key: cord-0794747-5yxyy4ch
authors: Gong, Kuang; Wu, Dufan; Arru, Chiara Daniela; Homayounieh, Fatemeh; Neumark, Nir; Guan, Jiahui; Buch, Varun; Kim, Kyungsang; Bizzo, Bernardo Canedo; Ren, Hui; Tak, Won Young; Park, Soo Young; Lee, Yu Rim; Kang, Min Kyu; Park, Jung Gil; Carriero, Alessandro; Saba, Luca; Masjedi, Mahsa; Talari, Hamidreza; Babaei, Rosa; Mobin, Hadi Karimi; Ebrahimian, Shadi; Guo, Ning; Digumarthy, Subba R.; Dayan, Ittai; Kalra, Mannudeep K.; Li, Quanzheng
title: A Multi-Center Study of COVID-19 Patient Prognosis Using Deep Learning-based CT Image Analysis and Electronic Health Records
date: 2021-02-05
journal: Eur J Radiol
DOI: 10.1016/j.ejrad.2021.109583
sha: 6fab76179a14250afbe0a1fc11d6870f06d6815b
doc_id: 794747
cord_uid: 5yxyy4ch

PURPOSE: As of August 30th, there were in total 25.1 million confirmed cases and 845 thousand deaths caused by coronavirus disease of 2019 (COVID-19) worldwide. With overwhelming demands on medical resources, patient stratification based on their risks is essential. In this multi-center study, we built prognosis models to predict severity outcomes, combining patients’ electronic health records (EHR), which included vital signs and laboratory data, with deep learning- and CT-based severity prediction. METHOD: We first developed a CT segmentation network using datasets from multiple institutions worldwide. Two biomarkers were extracted from the CT images : total opacity ratio (TOR) and consolidation ratio (CR). After obtaining TOR and CR, further prognosis analysis was conducted on datasets from INSTITUTE-1, INSTITUTE-2 and INSTITUTE-3. For each data cohort, generalized linear model (GLM) was applied for prognosis prediction. RESULTS: For the deep learning model, the correlation coefficient of the network prediction and manual segmentation was 0.755, 0.919, and 0.824 for the three cohorts, respectively. The AUC (95% CI) of the final prognosis models was 0.85(0.77,0.92), 0.93(0.87,0.98), and 0.86(0.75,0.94) for INSTITUTE-1, INSTITUTE-2 and INSTITUTE-3 cohorts, respectively. Either TOR or CR exist in all three final prognosis models. Age, white blood cell (WBC), and platelet (PLT) were chosen predictors in two cohorts. Oxygen saturation (SpO2) was a chosen predictor in one cohort. CONCLUSION: The developed deep learning method can segment lung infection regions. Prognosis results indicated that age, SpO2, CT biomarkers, PLT, and WBC were the most important prognostic predictors of COVID-19 in our prognosis model.

Reverse-transcription polymerase chain reaction (RT-PCR) [2,3] assay is currently the mainstay for the diagnosis of COVID-19 pneumonia. While early diagnosis is the key to initiate patient isolation and contact tracing to reduce its spread, assessment and prediction of the severity of COVID-19 pneumonia is important to initiate supportive treatment, project need for hospital admission and anticipate the use of mechanical ventilation (MV) and transition to intensive care unit (ICU). Computed tomography (CT) provides important information in COVID-19 pneumonia, especially for patients with moderate to severe disease as well as those with worsening cardiopulmonary status. CT helps evaluate the infection severity based on presence, extent, and type of pulmonary opacities such as ground-glass opacity (GGO), consolidation, and J o u r n a l P r e -p r o o f crazy-paving patterns [4] [5] [6] . Radiologists can grade the imaging severity of pulmonary opacities using a point-based scoring system [7, 8] . However, such a scoring system is labor-intensive and can be timeconsuming.

Recently deep learning has been widely applied to various medical imaging applications. As for COVID- 19 , there are several reports on utilizing deep learning for accurate differentiation of COVID-19 from other lung diseases and segmenting the opacity regions [9] [10] [11] [12] [13] [14] [15] [16] . At the current resource-limited situation, prognosis prediction for COVID-19 is of paramount importance for patient management and decision making, e.g. MV usage and ICU admission. Several studies have explored the role of derived CT biomarkers for prognosis, alone [8, 17] or combined with electronic health records (EHR) [18, 19] , all based on datasets from one institution or country. Considering the differences in medical resources and public health strategies [20, 21] , it is unclear if the risk factors identified would be the same for different regions.

In this work, we explored the risk factors for COVID-19 prognosis based on datasets from multiple institutions across the world. We first developed a deep learning-based CT segmentation network using datasets from different countries. CT-based biomarkers, total opacity ratio (TOR), and consolidation ratio (CR) were derived based on the network output. The CT biomarkers were used together with the EHR data for prognosis analysis to identify potential predictors for patient severity outcomes.

Contributions of this work include two aspects: (1) deep learning-based CT image segmentation for COVID-19 pneumonia was developed and validated based on datasets from different institutions; (2) COVID-19 patient prognosis analysis was conducted based on datasets from multiple cohorts using both CT-derived biomarkers and EHR data.

This study was approved by the respective Institutional Review Boards (IRBs) and informed consent forms were waived due to the retrospective nature of this study. The whole dataset consisted of 369 non-contrast J o u r n a l P r e -p r o o f chest CT examinations of patients with RT-PCR assay positive COVID-19 pneumonia scanned between January 1, 2020 and March 30, 2020, from five hospitals across the world. Of these, manual segmentation of all regions with pulmonary opacities related to COVID- 19 Healthineers, Forchheim, Germany). All chest CT images were resampled to 5mm section thickness and 256 × 256 resolution in the transverse plane. All datasets were initially graded for the type of pulmonary opacities by two fellowship-trained thoracic subspecialty radiologists (XX and XXX with 16 and 13 years of clinical experience in thoracic imaging), who supervised the annotation of each opacity by two postdoctoral research fellows (with 1-2 years of experience in chest CT research). These manually segmented opacity regions were used as ground truth during network training and testing. For the datasets with EHR, detailed summaries are presented in Table 1 . A flowchart of the work is also given in Figure 1 for better understanding of the data organization and processing.

The network structure used in this work was based on a dense 3D network structure, which can fully extract features from input images because of better information propagation enabled by dense connections [22] .

The Diagram of the network structure is shown in Figure A. 1. It is composed of an encoder path to extract contextual features and a decoder path to recover the image details, which contains the dense blocks as well J o u r n a l P r e -p r o o f as transition-down and transition-up modules. Each convolutional kernel has the size of 3 × 3 × 3.

Transition-down module composes by a 1 × 1 × 1 convolution with stride 2 at X, Y axis which results in 1/2 spatial resolution reduction on the length and width of the input feature maps. It contains in-total 9 dense blocks, 4 transition-down and 4 transition-up modules. The last layer is a 1 × 1 × 1 convolution followed by the sigmoid activation function. The total number of trainable parameters for the network is 5.5 million.

To let the network focus on regions inside the lung, a lung mask was generated using a pretrained U-Net [23] . The network inputs were 3D CT images inside the lung mask and the outputs were the probability maps of the opacity regions inside the lung. The soft Dice [24] , defined as

was utilized as the objective function, where is the predicted probability map and is the binary ground truth. The soft Dice is an approximation of the Dice coefficient, which can directly use the outputted probability map without pre-defining the threshold. During testing, we used a threshold of 0.5 to generate the binary segmentation mask to calculate the Dice coefficient. The network was implemented based on TensorFlow 1.14 [25] . The Adam optimizer [26] was used during network training to optimize the softdice objective function.

During training and testing, we used 3D patches as the network input due to the graphics processing unit 

The segmentation network output regions of pulmonary opacities (inclusive of all opacities such as ground glass, consolidation, mixed and crazy paving patterns). After obtaining the regions of pulmonary opacities, a threshold of -200 Hounsfield unit (HU) [27] was used to demarcate the consolidation regions inside each pulmonary opacity. Signs of consolidation regions can indicate advanced or more severe disease forms.

Both the consolidation regions and the pulmonary-opacity regions are useful for CT biomarker derivations.

In our study, two biomarkers were extracted from the CT images based on the network output: TOR, which was defined as the volume of pulmonary-opacity regions divided by the total lung volume; and CR, which was defined as the volume of consolidated regions divided by the total lung volume. For prognosis and survival analysis, both the TOR and CR derived from the CT images were tested as potential predictors.

Note that all TOR and CR were calculated based on the network prediction and no TOR and CR were based on manual segmentations.

After obtaining TOR and CR, further prognosis analysis was conducted on datasets from three institutions: and CR for all three cohorts (P-value < 0.004), which might justify why CT derived biomarkers (TOR or CR) were predictors in both models #1 and #2.

We also studied the risk factors related to patients' survival time based on datasets from INSTITUTE-1

where the time points of mortality/discharge were available. 

There are various studies focusing on opacity-region segmentation from the COVID-19 CT datasets. Huang et al [12] have developed a CT segmentation network in order to perform serial quantitative CT assessment of COVID-19. To make the network training more efficient, Shan et al have devised a human-in-the-loop strategy to reduce the manual labelling efforts [28] . Chaganti et al [27] have designed a deep learning pipeline to perform semantic segmentation and various severity measures together. Fan et al [29] has developed a semi-supervised approach to alleviate the shortage of labelled data. To overcome the pitfalls of noisy labels, Wang et al [30] have developed a noise-robust segmentation network through the usage of a novel Dice loss and an adaptive self-ensembling training framework. Wu et al [31] have developed a weakly supervised network based on hybrid labels to segment both opacity and consolidation regions from COVID-19 CT datasets. Amyar et al [16] used the multi-task loss to improve the segmentation of infection regions in COVID-19 CT images. In this work, we developed a 3D dense network for CT image segmentation based on datasets from five institutes across the world. The dense network structure improved the segmentation performance over traditional UNet by reducing the number of training parameters [32] .

Two biomarkers, characterizing the opacities and consolidations, were derived from the network output. In [33, 34] and Sequential Organ Failure Assessment (SOFA) score, known risk factors of COVID-19 mortality [35] . Abnormal WBC count is also observed in other COVID-19 datasets [35, 38] . Previous studies [18, [35] [36] [37] [38] [39] [40] [41] [42] have also reported other laboratory tests as risk factors for adverse outcomes of COVID-19 pneumonia, including lactate dehydrogenase (LDH), lymphocyte count, and high-sensitivity C-reactive protein (hs-CRP). However, these factors were not significant predictors for prognosis based on our datasets. In [43] , CT images and laboratory tests were combined for the prognosis analysis, which used datasets from only one country. It showed that combining CT and lab tests can help improve the prognostic accuracy, indicating Albumin and C-reactive protein as important risk factors. These laboratory tests were not present in our prognosis models J o u r n a l P r e -p r o o f based on our datasets. The difference between our prognosis model and the prior investigations stated above might be due to difference in treatments, sample sizes, measurement time, or population, which deserves further investigations.

Our current study has several limitations. Due to the small sample size of the ICU patients in INSTITUTE-2 (10 out of 102), it is difficult to conclude that age and SpO2 were not risk factors for these patients. In addition, the EHR data came from different timepoints: it represented the last measurement before the CT scan in INSTITUTE-3 but on-admission measurement in INSTITUTE-1 and INSTITUTE-2. The hospitalized patients were more likely to be on supplemental oxygen therapy in INSTITUTE-3, which can explain the insignificant difference of SpO2 between the two groups as shown in Figure 6 . We also want to point out that the percentage of CT opacity regions to the whole lung depends on the timepoint when the CT scan was performed. For our prognosis model, the timepoint when the CT scan was performed was not considered in our prognosis model, which is one limitation of our study and other studies which use CT opacity as a biomarker without considering the time course. Currently Chest X-ray is widely used for prescreening and multiple timepoints of CXR are available. As the specificity of CXR is lower than CT regarding COVID-19, performance of biomarkers derived from CXR compared to CT is unknown.

Conducting prognosis analysis based on CXR and EHRs is one of our future directions. Finally, in this work the prognosis model was constructed for each institute individually, without building a unified prognosis model for all institutes. Reasons for not building a united model is due to different treatment policies among the institutes and also the differences of measurement time. Pursuing a united prognosis model is one of our future works.

In conclusion, based on datasets from multiple institutions across the three continents, we have developed a generalizable deep learning model to segment opacity regions based on CT images from COVID-19

patients. Prognosis analysis was conducted using the derived CT biomarkers and EHR data. Results

Informed consent Informed consent form was waived due to the retrospective nature of this study.

Author Quanzheng Li has received research support from Siemens Medical Solutions. Other authors declare that they have no conflict of interest.

This work was supported by the National Institutes of Health under grants RF1AG052653. The Wilcoxon signed-rank test was performed between the patient group with non-severe outcome and the patient group with severe outcomes. Correspondingly, *, **, and ns, located at the top of each bar plot, represents p-value<0.05, p-value <0.01, and non-significant, respectively. WBC = white blood cell; SpO2 = peripheral oxygen saturation; TOR = total opacity ratio; CR = consolidation ratio. 

Deep learning system to screen coronavirus disease 2019 pneumonia

Prior-Attention Residual Learning for More Discriminative COVID-19 Screening in CT Images

Deep-Learning Approach

Diagnosis of Coronavirus Disease 2019 (COVID-19) with Structured Latent Multi-View Representation Learning

Longitudinal Assessment of COVID-19 Using a Deep Learning-based Quantitative CT Pipeline: Illustration of Two Cases

COVIDiag: a clinical CAD system to diagnose COVID-19 pneumonia based on CT findings

Multi-task deep learning based CT imaging analysis for COVID-19 pneumonia: Classification and segmentation

Machine learningbased CT radiomics model for predicting hospital stay in patients with pneumonia associated with SARS-CoV-2 infection: A multicenter study

Predicting COVID-19 Malignant Progression with AI Techniques

Prediction of respiratory decompensation in Covid-19 patients using machine learning: The READY trial

Potential association between COVID-19 mortality and health-care resource availability

Modeling shield immunity to reduce COVID-19 epidemic spread

Automatic lung segmentation in routine imaging is a data diversity problem, not a methodology problem

V-Net: Fully convolutional neural networks for volumetric medical image segmentation

TensorFlow: Large-Scale Machine Learning on Heterogeneous Distributed Systems, ArXiv Prepr. ArXiv1603.04467

Adam: A Method for Stochastic Optimization

Quantification of Tomographic Patterns associated with COVID-19 from Chest CT

Lung Infection Quantification of COVID-19 in CT Images with Deep Learning

Inf-Net: Automatic COVID-19 Lung Infection Segmentation from CT Images

A Noise-Robust Framework for Automatic Segmentation of COVID-19 Pneumonia Lesions from CT Images

Severity and Consolidation Quantification of COVID-19 from CT Images Using Deep Learning Based on Hybrid Weak Labels

Gross tumor volume segmentation for head and neck cancer radiotherapy using deep dense multi-modality network

Thrombocytopenia and prognosis in intensive care

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

An interpretable mortality prediction model for COVID-19 patients

Multicenter Development and Validation of a Novel Risk Nomogram for Early Prediction of Severe 2019-Novel Coronavirus Pneumonia

ACP Risk Grade: A Simple Mortality Index for Patients with Confirmed or Suspected Severe Acute Respiratory Syndrome Coronavirus 2 Disease (COVID-19) During the Early Stage of Outbreak in Wuhan

Development and External Validation of a Prognostic Multivariable Model on Admission for Hospitalized Patients with COVID-19

Prediction of criticality in patients with severe Covid-19 infection using three clinical features: a machine learning-based prognostic model with clinical data in Wuhan

Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography

A dense 3D network was firstly trained with manual segmentation annotations as ground truth to predict the TOR. CR was then derived from the segmented results by thresholding at -200HU. The trained network was then used to process the CT images with EHR from INSTITUTE-1,2,3 to generate the corresponding TOR and CR biomarkers. At last, the TOR and CR biomarkers were combined with EHR

Cross validation (CV) was implemented using different number of folds at each site due to the different number of available datasets. Note that the three sites used the same vital sign variables but different lab tests

TOR = total opacity ratio; GLM: generalized linear model; EHR: electronic health records